title: Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.
abstract: BACKGROUND
  The oestrogen receptor status of a breast tumour predicts the response to hormonal treatment and is an important prognostic marker; women with oestrogen receptor positive tumours having a better short-term survival outcome.
  
  
  METHODS
  Kaplan-Meier estimates and Cox proportional hazard model were used to estimate the association between oestrogen receptor levels and long-term breast cancer-specific survival outcomes in 5735 women diagnosed with breast carcinoma from 1970 to 1997 in Western Australia. Further analysis was performed on a subset of women for whom biochemical and tumour characteristics were also available.
  
  
  RESULTS
  Five-year breast cancer-specific survival estimates for women with oestrogen receptor positive tumours was 0.85 (95% CI 0.84-86) compared to 0.72 (95% CI 0.70-74) for women with oestrogen receptor negative tumours. The relative survival advantage of an oestrogen positive tumour over oestrogen negative tumours disappeared by the fourth year (0.8, 95% CI 0.6-1.0). Conditional upon surviving 5 years, long-term breast cancer-specific survival was better for women with oestrogen receptor and progesterone receptor negative tumours compared to other women (log rank test P-value <0.05).
  
  
  CONCLUSIONS
  Despite an earlier survival advantage for women diagnosed with oestrogen receptor positive tumours, after 5 years of survival, women with oestrogen receptor negative and progesterone receptor negative tumours had better long-term survival outcomes from breast cancer compared to other women.
authors.affiliation: Centre for Molecular Immunology and Instrumentation, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. hahnel@cyllene.uwa.edu.au
authors.forename: Roland
authors.initials: R
authors.lastname: Hähnel
authors.forename: Katrina
authors.initials: K
authors.lastname: Spilsbury
mesh_terms: D001943:Breast Neoplasms / Q000737:chemistry / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011379:Prognosis; D016016:Proportional Hazards Models; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis; D016019:Survival Analysis; D013997:Time Factors; D014904:Western Australia / Q000453:epidemiology
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone